SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-041791
Filing Date
2014-07-07
Accepted
2014-07-07 17:30:59
Documents
4
Period of Report
2014-07-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v383354_8k.htm 8-K 25809
2 EXHIBIT 10.1 v383354_ex10-1.htm EX-10.1 201299
3 EXHIBIT 99.1 v383354_ex99-1.htm EX-99.1 9946
4 GRAPHIC image_005.jpg GRAPHIC 3720
  Complete submission text file 0001144204-14-041791.txt   243632
Mailing Address PEMBROKE HOUSE, 28-32 PEMBROKE ST UPPER DUBLIN L2 0000
Business Address PEMBROKE HOUSE, 28-32 PEMBROKE ST UPPER DUBLIN L2 0000 353971536401
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 14963700
SIC: 5531 Retail-Auto & Home Supply Stores